Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2022 Jul 28

PMID 35901361

Authors

Behzad Baradaran

Roya Nazmabadi

Zohreh Ariyan

Ebrahim Sakhinia

Hadi Karami

Affiliations

Soon will be listed here.

Abstract

Background: Acute myeloid leukemia (AML) is a type of blood cancer characterized by fast cellular proliferation. Myeloid cell leukemia-1 (Mcl-1) and survivin, as anti-apoptotic proteins, are involved in cancer growth and resistance to chemotherapy. The aim of this study was to examine the combination effect of Mcl-1 and survivin specific siRNAs on chemosensitivity of the human HL-60 AML cells.

Methods: SiRNAs transfection was performed by using Lipofectamine™2000 reagent. The mRNA expression was analyzed by real-time quantitative PCR. The apoptosis analysis was measured by ELISA cell death assay.

Results: siRNAs markedly suppressed mRNA expression levels of Mcl-1 and survivin in a time-dependent manner, resulting in reduction of leukemic cell proliferation and enhanced spontaneous cell death. Surprisingly, Mcl-1 siRNA and survivin siRNA synergistically enhanced the cell toxic effects of etoposide. Furthermore, down-regulation of Mcl-1 and survivin significantly enhanced the apoptotic effect of etoposide.

Conclusions: Our investigation suggests that suppression of Mcl-1 and survivin by siRNA can effectually inhibit cell growth and overcome chemoresistance of AML cells. Therefore siRNAs may be an important adjuvant in chemotherapy for AML patients.

Citing Articles

Enhancement of the Sensitivity of the Acute Lymphoblastic Leukemia Cells to ABT-737 by Formononetin.

Abbasi Y, Pooladi M, Nazmabadi R, Amri J, Abbasi H, Aghabeygi R Int J Mol Cell Med. 2024; 13(3):259-271.

PMID: 39493513 PMC: 11530950. DOI: 10.22088/IJMCM.BUMS.13.3.259.

Formononetin and Dihydroartemisinin Act Synergistically to Induce Apoptosis in Human Acute Myeloid Leukemia Cell Lines.

Abbasi Y, Pooladi M, Nazmabadi R, Amri J, Abbasi H, Karami H Cell J. 2024; 26(2):121-129.

PMID: 38459729 PMC: 10924837. DOI: 10.22074/cellj.2024.2016937.1459.

The Effects of ABT-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and KG-1 Cancer Cells.

Nazmabadi R, Pooladi M, Amri J, Darvish M, Abbasi Y, Karami H Asian Pac J Cancer Prev. 2024; 25(1):343-350.

PMID: 38285802 PMC: 10911724. DOI: 10.31557/APJCP.2024.25.1.343.

Dihydroartemisinin Enhances the Therapeutic Efficacy of BH3 Mimetic Inhibitor in Acute Lymphoblastic Leukemia Cells via Inhibition of Mcl-1.

Nazmabadi R, Pooladi M, Amri J, Abbasi Y, Karami H, Darvish M Asian Pac J Cancer Prev. 2024; 25(1):325-332.

PMID: 38285800 PMC: 10911722. DOI: 10.31557/APJCP.2024.25.1.325.

References

Montecucco A, Biamonti G . Cellular response to etoposide treatment. Cancer Lett. 2006; 252(1):9-18. DOI: 10.1016/j.canlet.2006.11.005. View

Xu J, Ren X, Pathania A, Fernandez G, Tran A, Zhang Y . PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. Sci Rep. 2017; 7(1):835. PMC: 5429784. DOI: 10.1038/s41598-017-00947-6. View

Greiner J, Gotz M, Bunjes D, Hofmann S, Wais V . Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients. J Clin Med. 2019; 9(1). PMC: 7019914. DOI: 10.3390/jcm9010039. View

Ryan B, ODonovan N, Duffy M . Survivin: a new target for anti-cancer therapy. Cancer Treat Rev. 2009; 35(7):553-62. DOI: 10.1016/j.ctrv.2009.05.003. View

Balaji S, Terrero D, Tiwari A, Ashby Jr C, Raman D . Alternative approaches to overcome chemoresistance to apoptosis in cancer. Adv Protein Chem Struct Biol. 2021; 126:91-122. DOI: 10.1016/bs.apcsb.2021.01.005. View

Yoo J, Yeh M, Wang Y, Oh C, Zhao Z, Kaur B . MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin. Biomedicines. 2021; 9(7). PMC: 8301402. DOI: 10.3390/biomedicines9070780. View

Liu X, Tang H, Chen J, Song C, Yang L, Liu P . MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer. Oncotarget. 2015; 6(24):20070-83. PMC: 4652988. DOI: 10.18632/oncotarget.4039. View

Filipchiuk C, Lagana A, Beteli R, Ponce T, Christofolini D, Trevisan C . /Survivin Expression as a Non-Invasive Biomarker of Endometriosis. Diagnostics (Basel). 2020; 10(8). PMC: 7459871. DOI: 10.3390/diagnostics10080533. View

Alamdari-Palangi V, Amini R, Karami H . MiRNA-7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS-1 and IRS-2 expression. J Pharm Pharmacol. 2020; 72(4):531-538. DOI: 10.1111/jphp.13226. View

10.

Karami H, Baradaran B, Esfahani A, Sakhinia M, Sakhinia E . Therapeutic Effects of Myeloid Cell Leukemia-1 siRNA on Human Acute Myeloid Leukemia Cells. Adv Pharm Bull. 2014; 4(3):243-8. PMC: 3992959. DOI: 10.5681/apb.2014.035. View

11.

de Necochea-Campion R, Shouse G, Zhou Q, Mirshahidi S, Chen C . Aberrant splicing and drug resistance in AML. J Hematol Oncol. 2016; 9(1):85. PMC: 5018179. DOI: 10.1186/s13045-016-0315-9. View

12.

Quinn B, Dash R, Azab B, Sarkar S, Das S, Kumar S . Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig Drugs. 2011; 20(10):1397-411. PMC: 3205956. DOI: 10.1517/13543784.2011.609167. View

13.

Li X, Liang J, Liu Y, Wang Y, Yang X, Bao-Hongluan . Knockdown of the FoxM1 enhances the sensitivity of gastric cancer cells to cisplatin by targeting Mcl-1. Pharmazie. 2016; 71(6):345-8. View

14.

Shahverdi M, Amri J, Karami H, Baazm M . Knockdown of Myeloid Cell Leukemia-1 by MicroRNA-101 Increases Sensitivity of A549 Lung Cancer Cells to Etoposide. Iran J Med Sci. 2021; 46(4):298-307. PMC: 8288490. DOI: 10.30476/ijms.2020.83173.1203. View

15.

Hormi M, Birsen R, Belhadj M, Huynh T, Cantero Aguilar L, Grignano E . Pairing MCL-1 inhibition with venetoclax improves therapeutic efficiency of BH3-mimetics in AML. Eur J Haematol. 2020; 105(5):588-596. DOI: 10.1111/ejh.13492. View

16.

Rathore R, McCallum J, Varghese E, Florea A, Busselberg D . Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs). Apoptosis. 2017; 22(7):898-919. PMC: 5486846. DOI: 10.1007/s10495-017-1375-1. View

17.

Beekman A, OConnell M, Howell L . Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1). ChemMedChem. 2015; 11(8):840-4. PMC: 4848766. DOI: 10.1002/cmdc.201500488. View

18.

Yu X, Du J, Fan Y, Liu F, Cao L, Liang N . Retraction: Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Oncotarget. 2019; 10(41):4252. PMC: 6609247. DOI: 10.18632/oncotarget.27064. View

19.

Zareifar S, Ghorbani S, Monabbati A, Bordbar M, Zekavat O, Abdolkarimi B . Expression of antiapoptotic proteins livin and survivin in pediatric AML patients, as prognostic markers. Pediatr Hematol Oncol. 2018; 35(4):250-256. DOI: 10.1080/08880018.2018.1530702. View

20.

Zaffaroni N, Pennati M, Daidone M . Survivin as a target for new anticancer interventions. J Cell Mol Med. 2005; 9(2):360-72. PMC: 6740253. DOI: 10.1111/j.1582-4934.2005.tb00361.x. View